| 发明名称 |
METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF THE NEUROPATHOLOGY OF PATIENTS SUFFERING FROM MYOTONIC DYSTROPHY TYPE 1 (DM1) |
| 摘要 |
The present invention relates to methods and pharmaceutical compositions for the treatment of the neuropathology of patients suffering from myotonic dystrophy type 1 (DM1). In particular, the present invention relates to a method of treating of the neuropathology of a patient suffering from myotonic dystrophy type 1 (DM1) comprising administering to the patient a therapeutically effective amount of an agent that normalizes, enhances, or potentiates glutamate uptake by glia. |
| 申请公布号 |
WO2016184911(A1) |
申请公布日期 |
2016.11.24 |
| 申请号 |
WO2016EP61134 |
申请日期 |
2016.05.18 |
| 申请人 |
INSERM (INSTITUT NATIONAL DE LA SANTÉ ET DE LA RECHERCHE MÉDICALE);UNIVERSITÉ PARIS DESCARTES;FONDATION IMAGINE;UNIVERSITÉ LIBRE DE BRUXELLES;ASSOCIATION INSTITUT DE MYOLOGIE;ASSISTANCE PUBLIQUE-HÔPITAUX DE PARIS (APHP) |
发明人 |
GOMES-PEREIRA, Mario;CHERON, Guy;GOURDON, Geneviève;SERVAIS, Laurent |
| 分类号 |
A61K31/43;A61K31/496;A61K31/498;A61K31/546;A61P25/00 |
主分类号 |
A61K31/43 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
